Adell Winley, P.A

NPI: 1154546232
Total Payments
$4,937
2024 Payments
$1,482
Companies
24
Transactions
327
Medicare Patients
2,013
Medicare Billing
$169,646

Payment Breakdown by Category

Food & Beverage$4,873 (98.7%)
Education$63.73 (1.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,873 322 98.7%
Education $63.73 5 1.3%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,307 146 $0 (2024)
ABBVIE INC. $508.74 24 $0 (2024)
Janssen Biotech, Inc. $413.60 15 $0 (2024)
Celgene Corporation $406.79 37 $0 (2024)
QOL Medical, LLC $400.67 15 $0 (2024)
Ferring Pharmaceuticals Inc. $266.94 19 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $226.03 11 $0 (2024)
PFIZER INC. $197.79 9 $0 (2024)
E.R. Squibb & Sons, L.L.C. $197.01 2 $0 (2023)
Ardelyx, Inc. $183.31 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,482 70 QOL Medical, LLC ($246.36)
2023 $1,928 116 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($510.57)
2022 $1,188 102 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($397.18)
2021 $338.80 39 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($179.67)

All Payment Transactions

327 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/13/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $26.32 General
Category: Immunology
12/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $4.49 General
Category: Gastroenterology
12/04/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $30.58 General
Category: GASTROENTEROLOGY
11/25/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $9.50 General
Category: Gastroenterology
11/25/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $7.21 General
Category: Gastroenterology
11/19/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $20.78 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/18/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $13.92 General
Category: IMMUNOLOGY
11/13/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $14.79 General
Category: INFECTIOUS DISEASE
11/08/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $33.82 General
Category: LIVER DISEASE
11/07/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $23.23 General
Category: Immunology
11/07/2024 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $18.15 General
Category: ENDOCRINOLOGY
11/01/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $22.83 General
10/29/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $17.54 General
Category: GASTROENTEROLOGY
10/29/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $3.69 General
Category: ENDOCRINOLOGY
10/22/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $23.71 General
Category: Gastroenterology
10/16/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $121.84 General
Category: Immunology
10/14/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $28.01 General
Category: LIVER DISEASE
10/10/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $22.38 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $10.39 General
Category: Gastroenterology
10/08/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $27.84 General
Category: THERAPY FOR CSID
10/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $14.89 General
Category: Gastroenterology
10/01/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $19.79 General
Category: GASTROENTEROLOGY
09/27/2024 ABBVIE INC. CREON (Drug), LINZESS, VIBERZI Food and Beverage In-kind items and services $24.93 General
Category: ENDOCRINOLOGY
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $9.10 General
Category: Gastroenterology
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $0.35 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 517 527 $117,890 $38,513
2022 5 446 452 $95,250 $35,382
2021 12 737 1,352 $165,124 $69,321
2020 6 313 539 $67,171 $26,431
Total Patients
2,013
Total Services
2,870
Medicare Billing
$169,646
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 130 134 $31,495 $11,430 36.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 173 173 $38,430 $11,410 29.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 71 71 $23,865 $7,829 32.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 121 127 $20,750 $6,976 33.6%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 22 22 $3,350 $866.06 25.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 182 182 $38,220 $13,026 34.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 79 79 $24,885 $8,754 35.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 79 82 $16,810 $7,458 44.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 91 94 $13,160 $5,791 44.0%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 15 15 $2,175 $352.26 16.2%
99439 Chronic care management services, each additional 20 minutes of clinical staff time per calendar month Office 2021 108 410 $26,650 $12,015 45.1%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 138 138 $28,098 $10,963 39.0%
99490 Chronic care management services, first 20 minutes of clinical staff time per calendar month Office 2021 107 342 $25,650 $10,868 42.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 102 106 $21,191 $10,569 49.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 79 79 $23,455 $9,774 41.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 109 110 $15,320 $6,813 44.5%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2021 23 73 $12,775 $3,915 30.6%
99457 Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes Office 2021 12 35 $4,725 $1,422 30.1%
99487 Complex chronic care management services, first 60 minutes clinical staff time per calendar month Office 2021 15 15 $2,400 $1,104 46.0%
99202 New patient outpatient visit, total time 15-29 minutes Office 2021 18 18 $2,604 $941.76 36.2%
99489 Complex chronic care management services, each additional 60 minutes clinical staff time per calendar month Office 2021 15 15 $1,200 $528.00 44.0%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 11 11 $1,056 $407.61 38.6%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 56 56 $15,608 $6,243 40.0%
G2058 Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 fo Office 2020 34 180 $11,700 $5,324 45.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 65 66 $12,248 $4,933 40.3%

About Adell Winley, P.A

Adell Winley, P.A is a Physician Assistant healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154546232.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Adell Winley, P.A has received a total of $4,937 in payments from pharmaceutical and medical device companies, with $1,482 received in 2024. These payments were reported across 327 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,873).

As a Medicare-enrolled provider, Winley has provided services to 2,013 Medicare beneficiaries, totaling 2,870 services with total Medicare billing of $169,646. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Silver Spring, MD
  • Active Since 04/16/2007
  • Last Updated 07/07/2016
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1154546232

Products in Payments

  • XIFAXAN (Drug) $1,132
  • ZEPOSIA (Drug) $603.80
  • STELARA (Biological) $247.97
  • SUCRAID (Drug) $246.36
  • ENTYVIO (Biological) $226.03
  • XELJANZ (Drug) $197.79
  • IBSRELA (Drug) $183.31
  • TRULANCE (Drug) $168.92
  • Sucraid (Drug) $154.31
  • TREMFYA (Drug) $145.07
  • CIMZIA (Drug) $142.21
  • MAVYRET (Drug) $128.40
  • CREON (Drug) $115.01
  • DIFICID (Drug) $112.45
  • RINVOQ (Biological) $106.74
  • REBYOTA (Biological) $100.63
  • DUPIXENT (Biological) $100.34
  • SKYRIZI (Biological) $75.98
  • IDACIO (Biological) $71.91
  • SUTAB (Drug) $71.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Silver Spring